首页> 美国卫生研究院文献>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America >Monitoring of Early Warning Indicators for HIV Drug Resistance in Antiretroviral Therapy Clinics in Zimbabwe
【2h】

Monitoring of Early Warning Indicators for HIV Drug Resistance in Antiretroviral Therapy Clinics in Zimbabwe

机译:津巴布韦抗逆转录病毒疗法诊所中艾滋病毒耐药性预警指标的监测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Monitoring human immunodeficiency virus drug resistance (HIVDR) early warning indicators (EWIs) can help national antiretroviral treatment (ART) programs to identify clinic factors associated with HIVDR emergence and provide evidence to support national program and clinic-level adjustments, if necessary. World Health Organization–recommended HIVDR EWIs were monitored in Zimbabwe using routinely available data at selected ART clinics between 2007 and 2009. As Zimbabwe’s national ART coverage increases, improved ART information systems are required to strengthen routine national ART monitoring and evaluation and facilitate scale-up of HIVDR EWI monitoring. Attention should be paid to minimizing loss to follow-up, supporting adherence, and ensuring clinic-level drug supply continuity.
机译:监测人类免疫缺陷病毒耐药性(HIVDR)早期预警指标(EWI)可以帮助国家抗逆转录病毒治疗(ART)计划识别与HIVDR出现有关的临床因素,并在必要时提供证据支持国家计划和临床水平的调整。使用2007年至2009年期间在选定的ART诊所使用常规可用数据对世界卫生组织推荐的HIVDR EWI进行了监测。随着津巴布韦全国ART覆盖率的提高,需要改进的ART信息系统以加强常规的国家ART监测和评估并促进扩大规模HIVDR EWI监控。应注意最大程度地减少随访损失,支持依从性并确保诊所级药物供应的连续性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号